Evidence map›Paper›PMID 35034567›Full record

ReviewExpert review of respiratory medicine2022

Demystifying idiopathic interstitial pneumonia: time for more etiology-focused nomenclature in interstitial lung disease.

Nevins W Todd, Sergei P Atamas, Stella E Hines, Irina G Luzina, Nirav G Shah, Edward J Britt, Andrew J Ghio, Jeffrey R Galvin

Open access · greenAbstract readReview
In one paragraph

Review in Expert review of respiratory medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. The Role of Particle Inhalation in Idiopathic Pulmonary Fibrosis.International journal of molecular sciences · 2025
    Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Nevins W ToddDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Sergei P AtamasDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Stella E HinesDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Irina G LuzinaDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Nirav G ShahDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Edward J BrittDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Andrew J GhioHuman Studies Facility, US Environmental Protection Agency, Chapel Hill, North Carolina, USA.
Jeffrey R GalvinDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
University of Maryland, Baltimore · USEnvironmental Protection Agency · US

Funding

Taming IL-33 to Control Inflammation and FibrosisR01AR077562 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI LUZINA, IRINA G. · 2021 to 2025
$1.7M
The Mechanisms of Profibrotic Sensitization by IL33R01HL126897 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI LUZINA, IRINA G. · 2015 to 2018
$1.4M
The Central Role of IL-33 in Immune-Mediated ScarringI01BX002499 · VA · BALTIMORE VA MEDICAL CENTER · PI LUZINA, IRINA G. · 2015 to 2020
–
BLRD VA I01 BX002499NHLBI NIH HHS R01 HL126897NIAMS NIH HHS R01 AR077562
6 · The paper itself

Abstract

introductionA major focus of interstitial lung disease (ILD) has centered on disorders termed idiopathic interstitial pneumonias (IIPs) which include, among others, idiopathic pulmonary fibrosis, idiopathic nonspecific interstitial pneumonia, cryptogenic organizing pneumonia, and respiratory bronchiolitis-interstitial lung disease. AREAS COVERED: We review the radiologic and histologic patterns for the nine disorders classified by multidisciplinary approach as IIP, and describe the remarkable amount of published epidemiologic, translational, and molecular studies demonstrating their associations with numerous yet definitive environmental exposures, occupational exposures, pulmonary diseases, systemic diseases, medication toxicities, and genetic variants. EXPERT OPINION: In the 21st century, these disorders termed IIPs are rarely idiopathic, but rather are well-described radiologic and histologic patterns of lung injury that are associated with a wide array of diverse etiologies. Accordingly, the idiopathic nomenclature is misleading and confusing, and may also promote a lack of inquisitiveness, suggesting the end rather than the beginning of a thorough diagnostic process to identify ILD etiology and initiate patient-centered management. A shift toward more etiology-focused nomenclature will be beneficial to all, including patients hoping for better life quality and disease outcome, general medicine and pulmonary physicians furthering their ILD knowledge, and expert ILD clinicians and researchers who are advancing the ILD field.

Indexed as

Idiopathic Interstitial PneumoniasIdiopathic Pulmonary FibrosisLung Diseases, InterstitialRadiologyHumansLungIdiopathic interstitial pneumoniaidiopathic pulmonary fibrosisinterstitial lung diseasenonspecific interstitial pneumoniaorganizing pneumoniausual interstitial pneumonia

Identifiers

PMID35034567
PMCPMC8983480
OpenAlexW4205729285

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.